Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
BCRF’s first venture funding is going to Clairity Inc., which uses AI to analyze routine mammograms and predict a woman’s five-year risk of developing cancer.
New research could provide useful information for cancer registries and potentially help policymakers better evaluate screening outcomes to develop more effective guidelines.
Questions about menopause, oral contraceptive use and hormone replacement therapy should all be part of the conversation when evaluating a woman's cardiovascular health.
Vara announced the achievement on Sept. 3, with the Berlin, Germany-based technology firm earning CE Certification under the EU's Medical Device Regulation.
“Some clinical image quality deficiencies were severe,” the agency said, adding that the center is now required to submit an “extensive corrective action plan to the ACR.”
Breast arterial calcifications are the most common finding associated with cardiovascular diseases on mammograms, but new technology can assess further to predict patients’ CVD risk.
New survey data suggest that although AI tools have improved certain aspects of breast cancer screening processes, the benefits have not yet translated into improved outcomes.